Biogenomics Ltd sell "Insulin Aspart"
Basic Information
614
32
14
4.9(11)
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Insulin Aspart
Details
Substance
Manufacturer(s)
Specifications
- CAS Number: 116094-23-6
- Chemical Formula: C256H387N65O79S6
- Indication: Blood glucose management in diabetes mellitus, as a biosimilar referencing NovoRapid
- IUPAC Name: (4S)-4-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoy
- EC Number:
- Molecular Weight: 5832
- Regulatory Approval Status: Developed to meet international approval standards as a biosimilar insulin product
- Dosage Form: Solution for injection, consistent with rapid-acting insulin analog presentations
Other Information
Additional Description:
A biosimilar insulin aspart, referencing NovoRapid as the reference product.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment